Results

Total Results: 859 records

Showing results for "last months".

221. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
     November 01, 2012 - The dates for this scan can begin from the last search date of the most recent high-quality systematic … In the absence of a recent high- quality systematic review, a feasibility scan of the last 5 or 10 years … The potential of a new review to have significant health impact is the last set of criteria considered … Are there landmark trials published since the last systematic review? 20. … nominations on average are triaged per month, and the mean time from nomination submission to triage is 7 months

222. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - The purpose of this surveillance report is to describe new studies identified since the last search … evidence, in patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to <6 months … : Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months … Background Chronic pain is defined as pain lasting longer than 3 to 6 months or past normal time for … , 6 to 12 months, and ≥12 months).4-8 Meta-analyses were conducted to summarize data and obtain more

223. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
     December 31, 2013 - were above the normal reference range at baseline (236 mg⁄ dl placebo; 234 mg⁄ dl linagliptin) and at last … The mean changes from baseline to the last value on treatment for total cholesterol, HDL cholesterol … 12 months Glycemic control, insulin resistance, and beta-cell function variables Decrease … Exenatide + metformin were superior to placebo + metformin in reducing HbA1c at 12 months (P < 0.05 … Significant decrease of waist circumference, and hip circumference after 12 months (P < 0.01, and P

224. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
     October 01, 2010 - Trials with a duration of 6 months were meta-analyzed separately from trials with a duration of 1 year … The last study did not specify whether the FEV1 was absolute or percent predicted. … In months 6 to 12, females had greater height and weight velocities than males. … In the relatively low doses used in CF patients for a time period of 6 to 12 months, rhGH therapy may … – Trials with treatment durations of 6 months or of 12 months or longer would be helpful in determining

225. Migraine-Adults-Executive-130408 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
     April 01, 2013 - headache on most days of the month.17,18 Often, preventive treatment is recommended for only 6 to 9 months … RCTs enrolled on average 210 adults, measured the outcomes at 2 to 3 months of followup, and reported

226. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
     April 18, 2013 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … Pediatric safety trials should examine adverse effects at 12 months or more. … Disorders (ICHDII), migraine is a common disabling primary headache disorder anifesting in attacks that last … small nonrandomized study demonstrated that 8 percent of adolescents treated with botox 100U every 3 months

227. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
     March 21, 2013 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … for this review includes nonpregnant women from menarche to menopause who have had AUB for three months … At the outset, they seem to state that they will utilize these systems, but that is basically the last … complaints of chronic irregular uterine bleeding (problem bleeding [frequent or infrequent] of 3 months … defects, and related systemic disease) or abnormal cyclic uterine bleeding (Problem bleeding of 3 months

228. Insomnia_protocol-140403 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_protocol-140716.pdf
     April 03, 2014 - ) and occur despite adequate opportunity for sleep on at least 3 nights per week for at least three months … 17 percent of U.S. adults reporting “regularly having insomnia or trouble sleeping in the past 12 months … timeframe for sleep difficulties; chronic insomnia was used to describe cases that lasted from weeks to months … Timing KQ1: Outcomes measured at 4 weeks to 3 months after initiation of treatment will be used to … o sustained efficacy/comparative effectiveness: over 3 months • subgroups of adults: older adults

229. Insomnia_protocol-140403 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_research-protocol.pdf
     April 03, 2014 - and occur despite adequate opportunity for sleep on at least 3 nights per week for at least three months … 17 percent of U.S. adults reporting “regularly having insomnia or trouble sleeping in the past 12 months … timeframe for sleep difficulties; chronic insomnia was used to describe cases that lasted from weeks to months … Timing KQ1: Outcomes measured at 4 weeks to 3 months after initiation of treatment will be used to … o sustained efficacy/comparative effectiveness: over 3 months • subgroups of adults: older adults

230. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - ), intermediate-term treatment duration (6 to <12 months), and long- term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months), and long-term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months), and long-term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months), and long- term treatment duration (≥12 months … 12 months), and long-term treatment duration (≥12 months) • We will assess available literature to

231. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
     January 15, 2016 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … These lesions present earlier and have the majority of their growth in the first 3-4 months of life … they may have more prolonged growth (or could say that the proliferative phase may be more prolonged/last … Peer reviewer #4 Results Page 22, last paragraph, not clear that the final model used common variance … Peer reviewer #4 Results Page 34, last paragraph, are the conflicting findings still combinable?

232. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
     December 20, 2018 - Reviewer #1 Introduction Page 4, lines 26-32 The logic of the first part of the paragraph vs the last … We have modified the text to incorporate the same subject (drugs) into the first and last sentence. … Most recently, early RA has been defined as < 6 months from onset of symptoms [1] and within 3 months … added a brief summary statement to the Evidence Summary (Limitations to the Evidence Base - second to last … considered the AMPLE trial for inclusion previously when BMS sent us supplemental evidence and data last

233. Behavioral Interventions for Migraine Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bimp-protocol.pdf
     September 27, 2022 - To inform the contextual questions, we will search the last five years for pertinent survey and qualitative … The disposition of comments for systematic reviews and technical briefs will be published 3 months after

234. Disposition of Comments for CER 195 Management of Uterine Fibroids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
     December 14, 2017 - We have noted that this is up to 24 months of follow-up. … Appendix H provides results at up to 6, 12, and 24 months. … Due to safety issues, the use of leuprolide is limited for only 3 months. … and Affiliation Section Comment Response Peer Reviewer #2 Results Page 45, Table 21: the next to last … Assume it is months, but it could easily be another unit of time.

235. Methods Research Report: Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive Web-Based Presentation and Discussion of Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
     October 01, 2018 - Over several months, we developed, implemented, and evaluated a 1-hour interactive, web-based presentation … Process Description This project spanned several months (Table 1). … Last, our interviewees advocated for health system participation in the scoping of evidence reviews, … some details that will inform implementation of the lifestyle interventions, as you listen to the last … group as evidence by 50% meeting wt loss goals and ¾ meeting exercise goals during the initial 6 months

236. hemangioma-protocol-141223 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
     December 23, 2014 - in most patients in the first few weeks of life and reach 80 percent of total size by around age 3 months … Meta-Analyses We identified 13 treatment-focused systematic reviews or meta-analyses published in the last … ) • Long-term (> 3 months) Setting • Inpatient and outpatient settings (e.g., pediatric radiology … ) • Long-term (> 3 months) Setting • Inpatient and outpatient settings (e.g., pediatric radiology … ) or Long-term (> 3 months) • Inpatient and outpatient settings (e.g., pediatric radiology clinic,

237. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - We will require at least six months of treatment. … Final health  or patient-­ centered  outcomes: Incident MCI or  AD Timing Minimum followup  of 6   months … for intermediate   outcomes Minimum followup  of 6   months for intermediate   outcomes None Settings … The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of LifeBurden of Health … The disposition of comments for systematic reviews and technical briefs will be published three months

238. Rapid Evidence Product_Assisted Home Dialysis in the United States: New Interest in an Old Idea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/home-dialysis-ESKD-rapid-research.pdf
     April 01, 2025 - Now that he can’t do it by himself, the traditional route would be to get him to spend the last of … and to the choice of older patients to remain on PD until death rather than transfer to HD in their last … months of life. … NR Long-term [Median PD duration: 16.5 months (IQR: 7.8-29.7)] 20 Country Study, Year … Trends in assisted peritoneal dialysis over the last decade: a cohort study from the French Peritoneal

239. Clinical-Care-Rapid-Review-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
     January 01, 2018 - , community hospitals Preimplementation, Cumulative rate of closure at 36 months Pre-implementation, … , Cumulative rate of closure at 36 months Pre-implementation, at 36 months NR Events: AMC1: 67% AMC2 … , AMCs Post-implementation, Cumulative rate of closure at 36 months Post-implementation, at 36 months … hospitals, AMCs Post-implementation, Cumulative rate of closure at 36 months Post-implementation, at … , at 36 months NR Events: 62% NA NA NA Evidence Table C-13 Evidence Table C-13.

240. Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
     April 03, 2013 - The new text is now the last 6 paragraphs of the Applicability section of the full report and includes … this comment and other comments from Peer Reviewer #3 (and other reviewers), we realize that the last … of diagnosis or 3 months or 1 year. … , and 6 months. … The new text is now the last 6 paragraphs of the Applicability section of the full report and includes